The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty

Int J Cardiol. 2002 Jun;83(3):249-57. doi: 10.1016/s0167-5273(02)00073-6.

Abstract

Objectives: Coronary angioplasty remains plagued by the problem of restenosis. Genetic polymorphisms may contribute to the development of restenosis by mediating exaggerated inflammatory responses of the endothelium to angioplasty-induced injury.

Background: The serine (Ser)-128-arginine (Arg) gene polymorphism of E-selectin has been implicated in the pathogenesis of coronary artery disease (CAD). We sought to explore whether allelic variants relate to post-angioplasty restenosis.

Methods: The 128Arg allele was analyzed by PCR in 101 (derivation study, age 54+/-1 years, all mean+/-S.E.M.) and 92 (validation study, age 62+/-1 years) patients with CAD who underwent successful angioplasty.

Results: Restenosis, defined as >50% luminal diameter reduction at the target lesion at follow-up angiography, was found in 54/101 (53%) and 43/92 (47%) patients during follow-up. The 128Arg allele frequency in the derivation study was 10.39% and was 11.96% in the validation study. The 128Arg allele was more prevalent in the restenosis groups (14.81% and 17.44%, respectively) than in the restenosis-free groups (5.32% and 7.14%, respectively, p=0.027 and p=0.031). In multivariate logistic regression, the 128Arg allele emerged as a predictor of restenosis in both studies (p<0.05). There were no differences in the level of soluble E-selectin according to genotype, gender, age (p>0.20), and between patients with restenosis and those without (43.8+/-3.2 vs. 47.4+/-3.1 ng/ml, p>0.20).

Conclusions: The 128Arg allele of E-selectin may be related to increased endothelial responses to injury, thereby potentially serving as a risk factor for post-angioplasty restenosis in patients with CAD.The development of restenosis remains a problem in patients with CAD. The Ser128Arg polymorphism of E-selectin was analyzed in 101 (derivation) and 92 (validation) CAD patients. Patients with restenosis (54/101 and 43/92) had a higher frequency of the 128Arg allele (14.81 and 17.44%) than those without (5.32%, p=0.027 and 7.14%, p=0.031). In logistic regression, the 128Arg allele emerged as a predictor of restenosis in both studies (p<0.05). The E-selectin 128Arg allele may serve as a risk factor for the development of restenosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angioplasty, Balloon, Coronary / adverse effects*
  • Arginine / genetics
  • Coronary Angiography
  • Coronary Disease / genetics*
  • Coronary Disease / therapy
  • Coronary Restenosis / genetics
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Membrane Glycoproteins / genetics*
  • Middle Aged
  • Myocardial Infarction / genetics*
  • Polymorphism, Genetic / genetics*
  • Predictive Value of Tests
  • Receptors, Fibroblast Growth Factor / genetics*
  • Serine / genetics
  • Sialoglycoproteins
  • Treatment Outcome

Substances

  • Membrane Glycoproteins
  • Receptors, Fibroblast Growth Factor
  • Sialoglycoproteins
  • cysteine-rich fibroblast growth factor receptor
  • Serine
  • Arginine